Diverse alterations associated with resistance to KRAS(G12C) inhibition
暂无分享,去创建一个
M. Berger | J. Reis-Filho | B. Weigelt | Gregory Riely | K. Arora | Y. Murciano-Goroff | E. de Stanchina | J. Lipford | P. Lito | T. T. Mai | Bob T. Li | L. Lim | Jenny Y. Xue | Dongsung Kim | K. Arbour | Chuanchuan Li | Yulei Zhao | A. Ang | J. Lucas | P. Achanta | Mark Li | A. Da Cruz Paula | Deanna Mohn | Amber Bahr | Brian Loomis | A. Y. Saiki | Anne Sisk | Rohan S Roy | Pragathi Achanta | T. Mai
[1] P. Jänne,et al. 99O_PR KRYSTAL-1: Activity and preliminary pharmacodynamic (PD) analysis of adagrasib (MRTX849) in patients (Pts) with advanced non–small cell lung cancer (NSCLC) harboring KRASG12C mutation , 2021 .
[2] C. Rudin,et al. Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer , 2020, Cell reports.
[3] P. Lito,et al. Targeting KRAS(G12C): From Inhibitory Mechanism to Modulation of Antitumor Effects in Patients , 2020, Cell.
[4] A. Abate,et al. Single cell mutation analysis of clonal evolution in myeloid malignancies , 2020, Nature.
[5] Davide Risso,et al. Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition , 2020, Nature.
[6] J. Fernandez-Banet,et al. The KRASG12C Inhibitor, MRTX849, Provides Insight Toward Therapeutic Susceptibility of KRAS Mutant Cancers in Mouse Models and Patients. , 2019, Cancer discovery.
[7] J. Desai,et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity , 2019, Nature.
[8] P. Rodriguez-Viciana,et al. SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamics , 2019, Proceedings of the National Academy of Sciences.
[9] J. Downward,et al. SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers , 2019, Nature Communications.
[10] P. Zarrinkar,et al. KRAS G12C NSCLC Models Are Sensitive to Direct Targeting of KRAS in Combination with PI3K Inhibition , 2018, Clinical Cancer Research.
[11] P. A. Futreal,et al. High-throughput single-cell DNA sequencing of acute myeloid leukemia tumors with droplet microfluidics , 2018, Genome research.
[12] P. Zarrinkar,et al. Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor , 2018, Cell.
[13] P. Poulikakos,et al. New perspectives for targeting RAF kinase in human cancer , 2017, Nature Reviews Cancer.
[14] Frank McCormick,et al. RAS Proteins and Their Regulators in Human Disease , 2017, Cell.
[15] Donavan T. Cheng,et al. Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients , 2017, Nature Medicine.
[16] Yi Liu,et al. Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State. , 2016, Cancer discovery.
[17] Neal Rosen,et al. Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism , 2016, Science.
[18] Donavan T. Cheng,et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.
[19] Steven J. M. Jones,et al. Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.
[20] Björn Usadel,et al. Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..
[21] Roland Seifert,et al. Faculty Opinions recommendation of K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. , 2013 .
[22] Kevan M. Shokat,et al. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions , 2013, Nature.
[23] Cole Trapnell,et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.
[24] D. Bar-Sagi,et al. RAS oncogenes: weaving a tumorigenic web , 2011, Nature Reviews Cancer.
[25] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[26] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[27] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[28] M. Ladanyi,et al. Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma , 2008, Clinical Cancer Research.
[29] B. Taylor,et al. V211D mutation in MEK1 causes resistance to MEK inhibitors in colon cancer. , 2019, Cancer discovery.
[30] M. Berger,et al. Abstract B015: An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer , 2018 .